Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07434180 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary

Study acronym: Lu-FAP CUP
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
The aim of the study is to test if a new radionuclide therapy, called 177-Lu-FAP-2286, works to treat cancer in patients with Cancer of Unknown Primary (CUP).
Trial Details
NCT Number NCT07434180
Lead Sponsor Peter MacCallum Cancer Centre, Australia
Collaborators: National Health and Medical Research Council, Australia, Novartis, SOFIE, University of Melbourne
Conditions
(from sponsor)
Cancer of Unknown Primary
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov